Breaking News Headlines Today

News from stocktitan.net

See all of stocktitan.net news coverage in one place. Discover how stocktitan.net’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 5,426 have been published by stocktitan.net which Ground News has aggregated in the past 3 months.

Ground News rates stocktitan.net’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

If you want to know if stocktitan.net is credible or reliable, look no further. We rank stocktitan.net as Unknown factuality. Find out more about our methodology here.

Information about stocktitan.net

Where is stocktitan.net located?stocktitan.net's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top stocktitan.net News

Electric Vehicles · Kentucky

Ford to Invest Nearly $2 Billion in Kentucky Assembly Plant to Produce Electric Vehicles

51% Center coverage: 65 sources

Ford says it will invest nearly $2 billion to retool a Kentucky plant to produce electric vehicles.See the Story

Real Estate · Arizona

Fathom Expands Market Share in Arizona by Licensing Its intelliAgent Platform to Sovereign Realty Partners

62% Center coverage: 32 sources

CARY, N.C., Aug. 11, 2025 /PRNewswire/ -- Fathom Holdings Inc. (Nasdaq: FTHM) ("Fathom" or the "Company") is proud to announce its expansion in the Arizona market through a strategic partnership with seasoned industry leaders Jeff Hawke, Joel Moyes, and Patrick…See the Story

Chevron · New York

Galaxy Appoints Matt Friedrich as Chief Legal Officer

62% Center coverage: 29 sources

Former Cognizant, Chevron Executive to Lead Regulatory and Policy Strategy See the Story

Hillenbrand Reports Fiscal Third Quarter 2025 Results

50% Center coverage: 26 sources

Revenue of $599 million decreased 24% compared to prior year; pro forma revenue decreased 10%GAAP EPS of $0.03 increased from $(3.53) in the prior year; adjusted EPS of $0.51 decreased 40% compared to prior yearAchieved $30 million of run-rate cost…Delaware, United States · Delaware See the Story

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders

94% Center coverage: 16 sources

SAN DIEGO, Aug. 11, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Corporation" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced the voting results from its Annual General Meeting (AGM) of Shareholders…San Diego · San Diego See the Story

Nano One Reports Q2 2025 Results and Summarizes Corporate Developments

34% Center coverage: 3 sources

Q2 2025 Results and Subsequent EventsJoplin · Joplin See the Story

Chipotle and Cava Put Rivalry on Pause with $25 Million Bet on Restaurant Automation

100% Center coverage: 1 sources

Cava CFO Tricia Tolivar speaks about the company's first major automation investment.United States · United States See the Story

Empress Amends 2025 Second Quarter MD&A

34% Center coverage: 3 sources

VANCOUVER, BC / ACCESS Newswire / August 12, 2025 / Empress Royalty Corp. (TSXV:EMPR)(OTCQX:EMPYF) ("Empress Royalty" or the "Company") has re-filed its Management's Discussion & Analysis ("MD&A") for the six months ended June 30, 2025 which was filed on SEDAR+…Vancouver, British Columbia · Vancouver See the Story

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering - Compass Therapeutics (NASDAQ:CMPX)

100% Center coverage: 1 sources

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. ("Compass") (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced the pricing of an underwritten public offering of 33,290,000 shares of its common stock at a price to the public of $3.00 per share and pre-funded warrants to purchase up to an aggregate of 6…Boston, Massachusetts · Boston See the Story

Stablecoin Leader USD1's CEO Takes Helm at ALT5 Following Massive $1.5B Investment Round

100% Center coverage: 1 sources

Digital asset trading platform ALT5 brings in World Liberty Financial leadership team, including Eric Trump as director, while securing major institutional backing. Learn more.Eric Trump See the Story

Figma and Motiff Reach Global Settlement in Intellectual Property Protection Lawsuits

100% Center coverage: 1 sources

SAN FRANCISCO--(BUSINESS WIRE)--Aug 12, 2025-See the Story

News from stocktitan.net